Enlarged Prostate (BPH) Latest Advances
Find the Latest Research About Enlarged Prostate (BPH)
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32423 publications
Quantification of tadalafil in HLMs using an ultrafast UPLC-MS/MS method to assess metabolic stability, including in silico analysis of metabolic lability, DEREK alerts, and ADME characteristics.
Journal: Analytical methods : advancing methods and applications
Published: September 07, 2026
Clinical efficacy and safety of a modified transurethral diode laser four-troughs vaporesection in treating benign prostatic hyperplasia
Journal: Zhonghua yi xue za zhi
Published: September 07, 2026
EScAPe: Eliminate Semantic Ambiguity in Prostate MRI Segmentation in Benign Prostatic Hyperplasia.
Journal: IEEE transactions on image processing : a publication of the IEEE Signal Processing Society
Published: September 03, 2026
Advances in the Prevention and Nursing Care of Postoperative Complications After Benign Prostatic Hyperplasia Surgery.
Journal: Archivos espanoles de urologia
Published: September 02, 2026
Comparisons of Clinical Outcomes Between the Three-Lobe and Two-Lobe Techniques in Holmium Laser Enucleation of the Prostate for Elderly Patients With Benign Prostatic Hyperplasia.
Journal: Archivos espanoles de urologia
Published: September 02, 2026
Benefits of cannabis in treating lower urinary tract symptoms: A scoping review.
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: September 01, 2026
Reply to Editorial Comment on "Endoscopic Outlet Surgery versus Medical Therapy for Benign Prostatic Hyperplasia: Impact on Incident Mood Disorders".
Journal: Urology
Published: August 30, 2026
Digital Subtraction Angiography of the Prostatic Artery in Vietnamese Men: Anatomical Variants and Collateral Pathways. A Prospective Observational Study.
Journal: La Clinica terapeutica
Published: August 28, 2026
Pharmacologic and clinical considerations of phosphodiesterase type 5 inhibitors and β-adrenergic receptor type 3 agonists for lower urinary tract symptoms and benign prostatic hyperplasia.
Journal: Expert opinion on drug metabolism & toxicology
Published: August 27, 2026
Association between estimated glucose disposal rate and benign prostatic hyperplasia: results from two nationally representative population-based studies.
Journal: The aging male : the official journal of the International Society for the Study of the Aging Male
Published: August 25, 2026
Last Updated: 09/26/2026